BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27492324)

  • 21. Modulatory effect of vanillic acid on antioxidant status in high fat diet-induced changes in diabetic hypertensive rats.
    Vinothiya K; Ashokkumar N
    Biomed Pharmacother; 2017 Mar; 87():640-652. PubMed ID: 28088113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).
    de Zeeuw D; Akizawa T; Agarwal R; Audhya P; Bakris GL; Chin M; Krauth M; Lambers Heerspink HJ; Meyer CJ; McMurray JJ; Parving HH; Pergola PE; Remuzzi G; Toto RD; Vaziri ND; Wanner C; Warnock DG; Wittes J; Chertow GM
    Am J Nephrol; 2013; 37(3):212-22. PubMed ID: 23467003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial.
    Joergensen C; Tarnow L; Goetze JP; Rossing P
    Diabet Med; 2015 Mar; 32(3):374-81. PubMed ID: 25307511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of garlic extract upon endothelial function, vascular inflammation, oxidative stress and insulin resistance in adults with type 2 diabetes at high cardiovascular risk. A pilot double blind randomized placebo controlled trial.
    Atkin M; Laight D; Cummings MH
    J Diabetes Complications; 2016; 30(4):723-7. PubMed ID: 26954484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small Molecule Inhibiting Nuclear Factor-kB Ameliorates Oxidative Stress and Suppresses Renal Inflammation in Early Stage of Alloxan-Induced Diabetic Nephropathy in Rat.
    Borgohain MP; Lahkar M; Ahmed S; Chowdhury L; Kumar S; Pant R; Choubey A
    Basic Clin Pharmacol Toxicol; 2017 May; 120(5):442-449. PubMed ID: 27888584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney.
    Anjaneyulu M; Chopra K
    Am J Nephrol; 2004; 24(5):488-96. PubMed ID: 15353911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma activity of the antioxidant enzymes in predicting diabetic nephropathy progression.
    Kovačević M; Mališ S; Pavlović D; Kovačević M; Savić Radojević A; Djukanović L
    Int Urol Nephrol; 2022 Jun; 54(6):1365-1372. PubMed ID: 34657239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers of Oxidative Stress in Diabetes Mellitus with Diabetic Nephropathy Complications.
    Goycheva P; Petkova-Parlapanska K; Georgieva E; Karamalakova Y; Nikolova G
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selenium-deficient diet induces renal oxidative stress and injury via TGF-beta1 in normal and diabetic rats.
    Reddi AS; Bollineni JS
    Kidney Int; 2001 Apr; 59(4):1342-53. PubMed ID: 11260395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
    Leehey DJ; Zhang JH; Emanuele NV; Whaley-Connell A; Palevsky PM; Reilly RF; Guarino P; Fried LF;
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2159-69. PubMed ID: 26482258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activities of xanthine oxidoreductase and antioxidant enzymes in different tissues of diabetic rats.
    Aliciguzel Y; Ozen I; Aslan M; Karayalcin U
    J Lab Clin Med; 2003 Sep; 142(3):172-7. PubMed ID: 14532905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT).
    Lambers Heerspink HJ; Weldegiorgis M; Inker LA; Gansevoort R; Parving HH; Dwyer JP; Mondal H; Coresh J; Greene T; Levey AS; de Zeeuw D
    Am J Kidney Dis; 2014 Feb; 63(2):244-50. PubMed ID: 24210590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receiver Operator Characteristic (ROC) Analysis of Lipids, Proteins, DNA Oxidative Damage, and Antioxidant Defense in Plasma and Erythrocytes of Young Reproductive-Age Men with Early Stages of Type 1 Diabetes Mellitus (T1DM) Nephropathy in the Irkutsk Region, Russia.
    Darenskaya M; Chugunova E; Kolesnikov S; Semenova N; Michalevich I; Nikitina O; Lesnaya A; Kolesnikova L
    Metabolites; 2022 Dec; 12(12):. PubMed ID: 36557320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Irbesartan delays progression of nephropathy as measured by estimated glomerular filtration rate: post hoc analysis of the Irbesartan Diabetic Nephropathy Trial.
    Evans M; Bain SC; Hogan S; Bilous RW;
    Nephrol Dial Transplant; 2012 Jun; 27(6):2255-63. PubMed ID: 22172728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study.
    Remuzzi G; Macia M; Ruggenenti P
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S90-7. PubMed ID: 16565256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tropisetron ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats.
    Barzegar-Fallah A; Alimoradi H; Asadi F; Dehpour AR; Asgari M; Shafiei M
    Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):361-8. PubMed ID: 25676798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of coenzyme Q10 supplementation on antioxidant capacity and inflammation in hepatocellular carcinoma patients after surgery: a randomized, placebo-controlled trial.
    Liu HT; Huang YC; Cheng SB; Huang YT; Lin PT
    Nutr J; 2016 Oct; 15(1):85. PubMed ID: 27716246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats.
    Chaudhry J; Ghosh NN; Roy K; Chandra R
    Life Sci; 2007 Feb; 80(12):1135-42. PubMed ID: 17234217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effect of esculetin on hyperglycemia-mediated oxidative damage in the hepatic and renal tissues of experimental diabetic rats.
    Prabakaran D; Ashokkumar N
    Biochimie; 2013 Feb; 95(2):366-73. PubMed ID: 23079336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.